1844 / 1851
CHALLENGES
3% of all patients in the USA are included
in the trials
Linking genetic-clinical data re missing
Even conventional prognostic factors are
changing (TNM)
Who should pay?
|
|
1844 / 1851
CHALLENGES
3% of all patients in the USA are included
in the trials
Linking genetic-clinical data re missing
Even conventional prognostic factors are
changing (TNM)
Who should pay?